Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria

FASEB Journal

Volumn 24, Issue 2, 2010, Pages 609-616

  Xu, Yizhen ^a   Zhang, Zhaoyun ^a   Hu, Ji ^a   Stillman, Isaac E ^b   Leopold, Jane A ^a   Handy, Diane E ^a   Loscalzo, Joseph ^a   Stanton, Robert C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Inflammation; Mouse kidney; Pentose phosphate pathway

Indexed keywords

8 ISOPROSTANE; ALBUMIN; BIOLOGICAL MARKER; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AGED; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; KIDNEY CORTEX; KIDNEY INJURY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL;

AGING; ALBUMINURIA; ANIMALS; ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; GLUTATHIONE; HETEROZYGOTE; HOMOZYGOTE; I-KAPPA B PROTEINS; KIDNEY CORTEX; MALE; MICE; NADP; NF-KAPPA B; OXIDATIVE STRESS; PROTEIN KINASE C; UP-REGULATION;

MUS;

EID: 76149131708     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-135731     Document Type: Article

References (32)

1. Munro, A. W., Girvan, H. M., and McLean, K. J. (2007) Cytochrome P450-redox partner fusion enzymes. Biochim. Biophys. Acta 1770, 345-359
2. Leopold, J. A., Cap, A., Scribner, A. W., Stanton, R. C., and Loscalzo, J. (2001) Glucose 6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases nitiric oxide bioavailability. FASEB J. 15, 1771-1773
3. Leopold, J. A., Zhang, Y. Y., Scribner, A. A., Stanton, R. C., and Loscalzo, J. (2003) Glucose 6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler. Thromb. Vasc. Biol. 23, 411-417
4. Horton, J. D. (2002) Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 30, 1091-1095
5. Muller, G., and Morawietz, H. (2009) NAD(P)H oxidase and endothelial dysfunction. Horm. Metab. Res. 41, 152-158
6. Pandolfi, P. P., Sonati, F., Rivi, R., Mason, P., Grosveld, F., and Luzzatto, L. (1995) Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 14, 5209-5215
7. Longo, L., Vanegas, O. C., Patel, M., Rosti, V., Li, H., Waka, J., Merghoub, T., Pandolfi, P. P., Notaro, R., Manova, K., and Luzzatto, L. (2002) Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J. 21, 4229-4239
8. Nicol, C. J., Zielenski, J., Tsui, L. C., and Wells, P. G. (2000) An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J. 14, 111-127
9. Lee, C. Y., Chasalow, F., Lee, S. M., Lewis, S., and Johnson, F. M. (1980) A null mutation of cytoplasmic malic enzyme in mice. Mol. Cell. Biochem. 30, 143-149
10. Ho, H. Y., Cheng, M. L., Lu, F. J., Chou, Y. H., Stern, A., Liang, C. M., and Chiu, D. T. (2000) Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. Free Radic. Biol. Med. 29, 156-169
11. Leopold, J. A., Walker, J., Scribner, A. W., Voetsch, B., Zhang, Y. Y., Loscalzo, A. J., Stanton, R. C., and Loscalzo, J. (2003) Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J. Biol. Chem. 278, 32100-32106
12. Tian, W.-N., Braunstein, L. D., Apse, K., Pang, J., Rose, M., Tian, X., and Stanton, R. C. (1999) Importance of glucose 6-phosphate dehydrogenase activity in cell death. Am. J. Physiol. Cell Physiol. 276, C1121-C1131
13. Tian, W.-N., Braunstein, L. D., Pang, J., Stuhlmeier, K., Xi, Q.-C., Tian, X., and Stanton, R. C. (1998) Importance of glucose 6-phosphate dehydrogenase activity for cell growth. J. Biol. Chem. 273, 10609-10617
14. Pretsch, W., Charles, D. J., and Merkle, S. (1988) X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus. Biochem. Genet. 26, 89-103
15. Sanders, S., Smith, D. P., Thomas, G. A., and Williams, E. D. (1997) A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiency. Mutat. Res. 374, 79-87
16. Xu, Y., Osborne, B. W., and Stanton, R. C. (2005) Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of protein kinase A which contributes to oxidative stress in rat kidney cortex. Am. J. Physiol. Renal Physiol. 289, F1040-F1047
17. Zhang, Z., Apse, K. J. P., and Stanton, R. C. (2000) High glucose inhibits glucose 6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J. Biol. Chem. 275, 40042-40047
18. Ahmad, F. K., He, Z., and King, G. L. (2005) Molecular targets of diabetic cardiovascular complications. Curr. Drug Targets 6, 487-494
19. Solt, L. A., and May, M. J. (2008) The IκB kinase complex: master regulator of NF-κB signaling. Immunol. Res. 42, 3-18
20. Cachofeiro, V., Goicochea, M., de Vinuesa, S. G., Oubina, P., Lahera, V., and Luno, J. (2008) Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int. 74(Suppl. 111), S4-S9
21. Rahangdale, S., Yeh, S. Y., Malhotra, A., and Veves, A. (2009) Therapeutic interventions and oxidative stress in diabetes. Front. Biosci. 14, 192-209
22. Touyz, R. M. (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248-252
23. Rosenstraus, M., and Chaisin, L. (1975) Isolation of mammalian cell mutants deficient in glucose 6-phosphate dehydrogenase activity: Linkage to hypoxanthine phosphoribosyl transfererase. Proc. Nat. Acad. Sci. 72, 493-497
24. Suzuki, Y., and Sudo, J. (1989) Changes in glutathione peroxidase system and pyridine nucleotide phosphate levels in kidneys of cephaloridine- administered rats. Jpn. J. Pharmacol. 51, 181-189
25. Gaskin, R. S., Estwick, D., and Peddi, R. (2001) G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus. Ethn. Dis. 11, 749-754
26. Niazi, G. A. (1991) Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus. Int. J. Hematol. 54, 295-298
27. Panich, V., and Na-Nakorn, S. (1980) G6PD deficiency in senile cataracts. Hum. Genet. 55, 123-124
28. Wan, G. H., Tsai, S. C., and Chiu, D. T. (2002) Decreased blood activity of glucose-6-phosphate dehydrogenase associates with increased risk for diabetes mellitus. Endocrine. 19, 191-195
29. Kirkman, H. N., and Gaetani, G. F. (1984) Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. Proc. Natl. Acad. Sci. U. S. A. 81, 4343-4347
30. Kehrer, J. P., and Lund, L. G. (1994) Cellular reducing equivalents and oxidative stress. Free Radic. Biol. Med. 17, 65-75
31. Fornoni, A., Ijaz, A., Tejada, T., and Lenz, O. (2008) Role of inflammation in diabetic nephropathy. Curr. Diabetes. Rev. 4, 10-17
32. Suliman, M. E., Yilmaz, M. I., Carrero, J. J., Qureshi, A. R., Saglam, M., Ipcioglu, O. M., Yenicesu, M., Tong, M., Heimburger, O., Barany, P., Alvestrand, A., Lindholm, B., and Stenvinkel, P. (2008) Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 976-985